China OKs study of Telix PET radiotracer for kidney cancer

Telix Pharmaceuticals has received approval in China for a study of its investigationa...Read more on AuntMinnie.comRelated Reading: Telix and BAMF use Illuccix for total-body prostate PET Telix announces new CEO and dose of final patient in ZIRCON study Telix, Invicro further AI partnership Telix gets pass-through status for Illuccix Monrol to supply Telix with Lu-177 for renal cancer trial
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news